Home / Stocks / RNTX

RNTX insider trading

Rein Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
4
Bought · 24 mo
$625k
Buys · last 90 days
0 · $0
Most recent buy
2026-05-28

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-05-28VON RICKENBACH JOSEF H
Director
Bought47,060$1.06$50k
2026-05-13WINDSOR JAMES BRIAN
See Remarks
Bought25,000$1.00$25k
2025-11-18Cocke Travis W.
10% owner
Bought104,183$1.22$127k
2025-10-28Cocke Travis W.
10% owner
Bought306,050$1.38$423k

Most active insider buyers

InsiderRoleBuysTotal bought
Cocke Travis W.10% owner2$551k
VON RICKENBACH JOSEF HDirector1$50k
WINDSOR JAMES BRIANSee Remarks1$25k

See RNTX on the chart

Every insider buy and sell for RNTX plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.